4//SEC Filing
King Andrew James 4
Accession 0001209191-23-044071
CIK 0001435049other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 7:27 PM ET
Size
9.5 KB
Accession
0001209191-23-044071
Insider Transaction Report
Form 4
King Andrew James
Head of Renal Discovery
Transactions
- Sale
Common Stock
2023-08-01$39.03/sh−1,168$45,586→ 19,157 total - Exercise/Conversion
Restricted Stock Units
2023-07-29−3,333→ 6,667 totalExp: 2025-07-29→ Common Stock (3,333 underlying) - Exercise/Conversion
Common Stock
2023-07-29+3,333→ 20,325 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Each RSU represents a contingent right to receive one share of Issuer's common stock.
- [F4]The RSUs vest as to one-third (1/3) of the total award on the first, second, and third anniversaries of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823187
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 7:27 PM ET
- Size
- 9.5 KB